UPDATE: Pfizer (PFE) PT Raised to $42 at Morgan Stanley on Much Higher Vaccine Sales Projections
Tweet Send to a Friend
(Updated - May 10, 2021 7:32 AM EDT)
Morgan Stanley analyst David Risinger raised the price target on Pfizer ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Morgan Stanley analyst David Risinger raised the price target on Pfizer ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
